ARCHIVES

Satraplatin With Prednisone Reduces Risk Of Disease Progression By 33% In Study

This article is from The Cancer Letter archive.

Vol. 30 No. 3 | March 30, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Kennedy Drops Health Care Institute Plan Senate Approves Dole Amendment On Patents

August 18, 1978

Perifosine Increases PFS In Phase II Study

December 30, 2011

NCCN and Pfizer Issue RFP In Renal Cell Carcinoma Or Hematologic Malignancies

October 25, 2013

Therapeutic Vaccine May Fight Pancreatic Cancer

February 23, 2007

HEW Secretary Tells Ethics Board To Take Up Issue of Compensation

September 28, 1979

Immunotherapy Shrinks Tumors In Phase I Study at St. Jude

May 30, 2014